Anesthesia: Page 35

Study: MuGard effective against oral mucositis
By DrBicuspid.com staff writers
An ongoing research study of Access Pharmaceuticals' MuGard mucoadhesive oral wound rinse has found that it is effective in prevention, delay, and management of radiotherapy- and chemoradiotherapy- induced oral mucositis.
September 28, 2011
Univ. of Ala. researchers find new head/neck cancer strategy
By DrBicuspid.com staff writers
Combining the drug cetuximab with poly ADP-ribose polymerase inhibitors may improve outcomes in head and neck cancer patients by preventing the cancer cells from repairing damage to DNA as they grow, according to a study in PLoS One.
September 25, 2011
NCI grant to fund head/neck cancer drug study
By DrBicuspid.com staff writers
Researchers from Louisiana State University, the University of Chicago, and 13 other research institutions have been awarded a $1.24 million National Cancer Institute (NCI) grant to evaluate an immunosuppressant drug's potential to prevent the recurrence of head and neck cancer.
September 25, 2011
Licorice shows promise in preventing oral diseases
By Erin Archer, RN
Can a medicinal root that tastes like candy be used to prevent caries and treat alveolar bone loss in periodontal disease? A literature review in Oral Diseases found that licorice root appears to have many beneficial effects in the oral cavity, but the study authors caution that more clinical trials are needed.
September 20, 2011
2009 06 01 13 20 17 407 Licorice Sticks 70
DOCS Education updates sedation information website
By DrBicuspid.com staff writers
DOCS Education has recently revamped SedationRegulations.com, a free website that summarizes each U.S. state or Canadian province's sedation dentistry regulations, to demystify sedation regulations for dentists.
September 12, 2011
Milestone Scientific CFO takes on new role
By DrBicuspid.com staff writers
Milestone Scientific's chief financial officer (CFO) Joseph D'Agostino will also take on the role of chief operating officer.
September 11, 2011
FDA advisers consider time limit for bone drugs
By Reuters Health
ADELPHI, Md. (Reuters) - U.S. health advisers are considering a time limit for taking a class of drugs used by millions of women to prevent bone fractures, due to concerns over unusual fractures linked to the medicines and possible higher cancer rates.
September 8, 2011
2009 07 28 13 33 39 581 Fda Logo 70
FDA panels want revised labels on bisphosphonate drugs
By DrBicuspid.com staff writers
Manufacturers of bisphosphonate drugs such as Fosamax and Zometa should make changes to their product labeling to reduce the risk of bone fractures, two U.S. Food and Drug Administration (FDA) advisory panels concluded Friday.
September 8, 2011
FDA panels to review bisphosphonate risks
By DrBicuspid.com staff writers
Two U.S. Food and Drug Administration (FDA) advisory panels will meet this week to review the potential risks associated with long-term use of bisphosphonate medications such as Fosamax and to determine whether these drugs are safe and effective when used longer than three to five years, according to a story in the New York Times.
September 5, 2011
Miconazole tablets effective on candidiasis
By DrBicuspid.com staff writers
Miconazole buccal tablets are an effective treatment for oropharyngeal candidiasis, although the cost can be prohibitive for some patients, according to an article in the Journal of Patient Preference and Adherence.
August 25, 2011
Milestone Scientific Q2 revenues down 22%
By DrBicuspid.com staff writers
A decline in international revenue had a negative impact on Milestone Scientific's second-quarter financials. The company reported revenues of $2.5 million for the second quarter of 2011 (end-June 30), down from revenues of $3.2 million for the second quarter of 2010.
August 15, 2011
Leaders in Dentistry: A conversation with Dr. Joel Weaver
By Rob Goszkowski
Critical drug shortages, the safety of administering general anesthesia to very young patients, and state guidelines about which dentists can administer general anesthesia are all challenging aspects of dental anesthesiology. DrBicuspid.com spoke with Dr. Joel Weaver to get his perspective.
August 1, 2011
2011 08 02 09 39 13 321 Joel Weaver 70
Previous Page
Page 35 of 56
Next Page